Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Replimune Group Inc
7R8Current price
10.6 EUR
-0.1 EUR (-0.93%)
Last closed
11.4 USD
Company
www.replimune.com
ISIN
US76029N1063
Sector
Healthcare
Industry
Biotechnology
Exchange
Frankfurt Exchange
Capitalization
849 918 208 USD
Yield for 12 month
+4.65 %
1Y
3Y
5Y
10Y
15Y
7R8
Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development of oncolytic immunotherapies to treat cancer. The company's proprietary tumor-directed oncolytic immunotherapy product candidates are designed and intended to activate the immune system against cancer. Its lead product candidate is RP1, a selectively replicating version of HSV-1 that expresses GALV-GP R(-) and human GM-CSF, which is in Phase I/II clinical trials for a range of solid tumors. The company is also developing RP2, which is in Phase I clinical trials to express an anti-CTLA-4 antibody-like protein to block the inhibition of the immune response otherwise caused by CTLA-4; and RP3 that is in Phase I clinical trial to express immune-activating proteins that stimulate T cells. Replimune Group, Inc. was founded in 2015 and is headquartered in Woburn, Massachusetts. Address: 500 Unicorn Park Drive, Woburn, MA, United States, 01801
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
15.29 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
+4 042 000 USD
Current Year
-2 655 000 USD
Last Year
-2 447 000 USD
Current Quarter
-736 000 USD
Last Quarter
+3 387 000 USD
Key Figures 7R8
1 year
3 years
5 years
10 years
EBITDA
-231 756 992 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-25.74 %
PEG Ratio
–
Return On Equity TTM
-46.79 %
Wall Street Target Price
15.29 USD
Revenue TTM
–
Book Value
6.24 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-3.27 USD
Diluted Eps TTM
-3.27 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics 7R8
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 7R8
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation 7R8
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-0.2383
Price Book MRQ
1.993
Financials 7R8
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 7R8
For 52 weeks
4.92 USD
12.97 USD
50 Day MA
11.33 USD
Shares Short Prior Month
6 067 342
200 Day MA
8.94 USD
Short Ratio
7.92
Shares Short
7 163 072
Short Percent
15.19 %
BeatStart